LigandPharmaceuticals LGND full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Ligand Pharmaceuticals LGND WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange
operates under Health Care sector & deals in Major Pharmaceuticals
Daily price and charts and targets LigandPharmaceuticals
Strong Daily Stock price targets for LigandPharmaceuticals LGND are 180.76 and 185.37
| Daily Target 1 | 177.38 |
| Daily Target 2 | 179.52 |
| Daily Target 3 | 181.99333333333 |
| Daily Target 4 | 184.13 |
| Daily Target 5 | 186.6 |
Daily price and volume Ligand Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 17 October 2025 | 181.65 (0.49%) | 179.86 | 179.86 - 184.47 | 1.3588 times | Thu 16 October 2025 | 180.77 (-1.38%) | 184.18 | 178.34 - 186.48 | 1.3016 times | Wed 15 October 2025 | 183.30 (1.32%) | 181.26 | 178.68 - 185.70 | 0.9385 times | Tue 14 October 2025 | 180.92 (0.57%) | 179.28 | 177.76 - 182.13 | 0.7288 times | Mon 13 October 2025 | 179.89 (1.22%) | 178.68 | 177.85 - 181.35 | 0.6369 times | Fri 10 October 2025 | 177.73 (-2.52%) | 181.66 | 177.35 - 182.12 | 1.0009 times | Thu 09 October 2025 | 182.32 (-1.18%) | 183.14 | 181.94 - 185.07 | 0.6265 times | Wed 08 October 2025 | 184.49 (0.73%) | 184.47 | 182.52 - 186.40 | 1.0789 times | Tue 07 October 2025 | 183.16 (0.3%) | 183.76 | 179.40 - 183.76 | 0.8484 times | Mon 06 October 2025 | 182.61 (0.9%) | 182.00 | 181.45 - 184.26 | 1.4809 times | Fri 03 October 2025 | 180.99 (0.48%) | 180.12 | 179.21 - 183.81 | 1.2617 times |
Weekly price and charts LigandPharmaceuticals
Strong weekly Stock price targets for LigandPharmaceuticals LGND are 179.71 and 188.43
| Weekly Target 1 | 173.24 |
| Weekly Target 2 | 177.45 |
| Weekly Target 3 | 181.96333333333 |
| Weekly Target 4 | 186.17 |
| Weekly Target 5 | 190.68 |
Weekly price and volumes for Ligand Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 17 October 2025 | 181.65 (2.21%) | 178.68 | 177.76 - 186.48 | 0.7063 times | Fri 10 October 2025 | 177.73 (-1.8%) | 182.00 | 177.35 - 186.40 | 0.7164 times | Fri 03 October 2025 | 180.99 (6.64%) | 169.72 | 166.10 - 183.81 | 1.07 times | Fri 26 September 2025 | 169.72 (1.93%) | 167.38 | 163.45 - 172.45 | 0.9847 times | Fri 19 September 2025 | 166.51 (0.46%) | 165.63 | 161.82 - 170.78 | 2.4873 times | Fri 12 September 2025 | 165.75 (-0.6%) | 167.50 | 162.74 - 169.13 | 1.2468 times | Fri 05 September 2025 | 166.75 (3.12%) | 161.71 | 160.80 - 169.49 | 0.8062 times | Fri 29 August 2025 | 161.71 (0%) | 161.35 | 160.05 - 163.34 | 0.1812 times | Fri 29 August 2025 | 161.71 (1.65%) | 158.88 | 157.52 - 163.34 | 0.8143 times | Fri 22 August 2025 | 159.08 (5.3%) | 150.89 | 149.51 - 161.93 | 0.9867 times | Fri 15 August 2025 | 151.08 (0.68%) | 138.37 | 137.14 - 157.54 | 4.5012 times |
Monthly price and charts LigandPharmaceuticals
Strong monthly Stock price targets for LigandPharmaceuticals LGND are 178.61 and 189.53
| Monthly Target 1 | 170.31 |
| Monthly Target 2 | 175.98 |
| Monthly Target 3 | 181.23 |
| Monthly Target 4 | 186.9 |
| Monthly Target 5 | 192.15 |
Monthly price and volumes Ligand Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 17 October 2025 | 181.65 (2.55%) | 176.68 | 175.56 - 186.48 | 0.5329 times | Tue 30 September 2025 | 177.14 (9.54%) | 161.71 | 160.80 - 177.81 | 1.61 times | Fri 29 August 2025 | 161.71 (22.9%) | 131.00 | 129.55 - 163.34 | 2.1077 times | Thu 31 July 2025 | 131.58 (15.75%) | 112.42 | 111.72 - 143.13 | 1.279 times | Mon 30 June 2025 | 113.68 (11.24%) | 102.51 | 100.67 - 118.58 | 0.8854 times | Fri 30 May 2025 | 102.19 (-6.98%) | 110.67 | 98.89 - 111.42 | 0.8051 times | Wed 30 April 2025 | 109.86 (4.49%) | 104.95 | 93.58 - 112.55 | 0.6968 times | Mon 31 March 2025 | 105.14 (-13.98%) | 125.17 | 103.06 - 125.17 | 0.8432 times | Fri 28 February 2025 | 122.23 (4.87%) | 113.76 | 110.42 - 123.51 | 0.6056 times | Fri 31 January 2025 | 116.55 (8.77%) | 108.12 | 102.79 - 122.34 | 0.6344 times | Tue 31 December 2024 | 107.15 (-13.82%) | 124.78 | 105.00 - 125.50 | 0.7539 times |
Indicator Analysis of LigandPharmaceuticals
Tomorrow's movement Prediction of Ligand Pharmaceuticals LGND appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 180.06 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Ligand Pharmaceuticals LGND appears to be moving in a flat line. Not much is happening in the stock trend.
Tomorrow's movement Prediction of Ligand Pharmaceuticals LGND is strongly bullish. It has broken a strong resistance of 177 and is expected to move up further.
Munafa value: 85 as on Fri 17 October 2025
If this Munafa value is near or nearing 100, then this stock might show an upward movement. However, if this value is near or nearing 10, then this stock might very well show a downward movement.
If the Munafa value is near 50, then the stock might show a sideways movement.
SMA20 is at 178 and price is deviating by 6 points
Upper Bollinger band is at 189 and lower is at 167, while middle bands are at 173 and 184
Price is rising
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of LigandPharmaceuticals (LGND) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for LigandPharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for LigandPharmaceuticals in short term but the sell signal is initial and weak.
LigandPharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for LigandPharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of LigandPharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 181.75 and LigandPharmaceuticals LGND stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the LigandPharmaceuticals LGND stock. Volume based technical analysis of LigandPharmaceuticals LGND stock is negative.
LigandPharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Ligand Pharmaceuticals LGND
DMA (daily moving average) of Ligand Pharmaceuticals LGND
| DMA period | DMA value |
| 5 day DMA | 181.31 |
| 12 day DMA | 181.5 |
| 20 day DMA | 177.71 |
| 35 day DMA | 172.69 |
| 50 day DMA | 167.66 |
| 100 day DMA | 144.2 |
| 150 day DMA | 131.31 |
| 200 day DMA | 127.01 |
EMA (exponential moving average) of Ligand Pharmaceuticals LGND
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 181.38 | 181.24 | 181.48 |
| 12 day EMA | 180.06 | 179.77 | 179.59 |
| 20 day EMA | 177.54 | 177.11 | 176.72 |
| 35 day EMA | 172.38 | 171.83 | 171.3 |
| 50 day EMA | 166.86 | 166.26 | 165.67 |
SMA (simple moving average) of Ligand Pharmaceuticals LGND
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 181.31 | 180.52 | 180.83 |
| 12 day SMA | 181.5 | 181.28 | 180.98 |
| 20 day SMA | 177.71 | 176.95 | 176.4 |
| 35 day SMA | 172.69 | 172.12 | 171.53 |
| 50 day SMA | 167.66 | 167.03 | 166.34 |
| 100 day SMA | 144.2 | 143.4 | 142.6 |
| 150 day SMA | 131.31 | 130.81 | 130.31 |
| 200 day SMA | 127.01 | 126.65 | 126.28 |
Terms of Use Stock Market News! © munafasutra.org2025 All Rights reserved.